MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα

BACKGROUND: Metabolic abnormalities have been implicated as a causal event in diabetic cardiomyopathy (DCM). However, the mechanisms underlying cardiac metabolic disorder in DCM were not fully understood. RESULTS: Db/db mice, palmitate treated H9c2 cells and primary neonatal rat cardiomyocytes were...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cardiovasc Diabetol
Главные авторы: Yin, Zhongwei, Zhao, Yanru, He, Mengying, Li, Huaping, Fan, Jiahui, Nie, Xiang, Yan, Mengwen, Chen, Chen, Wang, Dao Wen
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2019
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6329097/
https://ncbi.nlm.nih.gov/pubmed/30635067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0811-7
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы